5. Conclusion
AS is a highly prevalent disease and its incidence is expected to
increase further, due to ageing population in India. The development of
MI approach has allowed surgeons to treat patients with multiple
co-morbidities. Perceval sutureless valve also enhances the feasibility
of MIAVR by quick and reproducible valve implantation along with
decalcification of the aortic annulus. In our limited experience, the
Perceval sutureless valve is most useful in MIAVR, combined procedure
and in high risk patient’s sensitive to x-clamp and CPB time. Rate of
Permanent Pacemaker implantation has been reduced significantly by
technical changes and it will further reduces with introduction of new
design Perceval sutureless valve. This valve also proves to be good
alternate to TAVI in cost reduction. Satisfactory mid-term and long-term
durability has been shown in various studies (18).
With increase in the number of Perceval sutureless valve implantation in
India, the experience of other surgeons and center will also contribute
to our findings and feasibility of its wide use.